Gender-specific differences in the incidence of microalbuminuria in metabolic syndrome patients after treatment with fimasartan: The K-MetS study-Reference-Cited by-同舟云学术

Gender-specific differences in the incidence of microalbuminuria in metabolic syndrome patients after treatment with fimasartan: The K-MetS study

Published:2017-12-19 Issue:12 Volume:12 Page:e0189342
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Park Jeong Bae^ORCID,Kim Su-A,Sung Ki-Chul,Kim Jang Young

Funder

Boryung Pharmaceutical Company

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference30 articles.

1. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement;SM Grundy;Circulation,2005

2. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies;AS Gami,2007

3. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study;AM McNeill,2005

4. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report,2002

5. International Obesity Task Force: Redefining Obesity and Its Treatment,2000

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of clinical treatments for metabolic syndrome on albuminuria: a systematic review protocol;REVISTA CIÊNCIAS EM SAÚDE;2023-03-28

2. Gender Differences in Chronic Kidney Disease. Findings from a Two Center Study in Nigeria;Archives Of Pharmacy Practice;2022

3. Biocrust Research in China: Recent Progress and Application in Land Degradation Control;Frontiers in Plant Science;2021-11-25